Published by Michele Maatouk on 6th July 2021
(Sharecast News) - AstraZeneca said on Tuesday that its $39bn proposed acquisition of US drug developer Alexion has been cleared by the European Commission.
URL: http://www.digitallook.com/dl/news/story/31966541/...